Hair cloning, also called “Stem Cell Re-genesis”, remains in phase 2 human clinical trials, where it has remained “stuck” for the past several years. Although researchers are staying rather tight lipped on the study, the word on the street is that results are not as promising as had been hoped based upon animal models prior to the human trials. It appears therefore that any commercial application of follicular stem cell technology remains years off. I will report more on the topic as new information is made available through professional channels.

Steven Paul Holt, MD, A.B.H.R.S.